Uzer KÜÇÜKTULU, Eray KURNAZ, Huseyin EKEN, Bilgin ÇELEBİ

Risk factors for axillary lymph node metastasis in breast cancer

Aim: As well as in Turkey as in the rest of the World, breast cancer is an increasing health problem. Although the axillary lymphnode dissection is seen as an integral part in the breast cancer treatment, for it provides staging and local control, it also leads tocomplications and morbidity.Material and Methods: We retrospectively reviewed the file of 286 patients which operated with breast cancer by January 2006 toJanuary 2017. We researched and tried to find factors that influence the axillary lymph nodes.Results: At 166 patients’ axillary lymph nodes has been found (58%). Literature shows factors that have a positive effect on axillarylymph node; age of patients, tumor location, and tumor histopathology and tumor size. We evaluated the above stated parameterswith statistical systems.Conclusion: Tumor size which is larger than 2 cm and invasive ductal carcinoma histopathology are risk factors on the axillary lymphnode metastases.

PDF

___

1. Haydaroğlu A, Dubova S, Özsaran Z. Ege Üniversitesinde meme kanserleri: 3897 olgunun değerlendirilmesi. Meme Sağlığı Dergisi 2005;1:10-2.
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, CACancer J Clin 2002;55:74-108.
3. Guiliano AE, Kirgan DM, Guenter JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;231,220:391-401.
4. Ozmen V. Breast cancer in the World and Turkey. J Breast Health 2008;4:6-12.
5. Seth Rummel, Matthew T Hueman, Nick Costantino, Craig D Shriver and Rachel E Ellsworth Tumour location within the breast: Does tumour site have prognostic ability? ecancer 2015;9:552.
6. Conzen SD, Grushko TA, Olopade OI. The Moleculer Biology of Breast Cancer 8th edition. 43;1595–1605.
7. Erdamar, S. Meme Karsinomlarında Histolojik Tipler ve Prognoz, Meme Hastalıkları, Editörler: Ünal G., Ünal H. Nobel Tıp Kitabevleri 2001;301-5.
8. İlvan Ş. Meme Karsinomu Patolojisi Meme Kanseri Sempozyum Dizisi No:70 4 Aralık 2006;65–71
9. Spatt JS, Donegan WL, Sigestad CP. Epidemiology and Etiology. In Donegan Wl, Spratt JS editors. Cancer of The Breast, Philadelphia, W.B. Saunders Co.1995.
10. Dalay N. Meme kanserinin biyolojik özellikleri Meme Kanseri. Nobel Tıp Kitapevi 2003.
11. Anderson JA, Page DL, The Breast. Oxford Textbook of Pathology Megee JOD, Isacson PG, Wright NA. Edition Oxford, Oxford Univercity Press; 1992. p. 1643-81.
12. Lee HS. Why is carcinoma of the breast more frequent in the upper outer quadrant? A case series based on needle core biopsy diagnoses. The Breast vol 2005;14:151-2.
13. Fisher B, Redmond C, Poison R, et al. Eight-year results of a randomizad clinical trial comparing total mastectomy and lumpectomy without irradition in the treatment of breast cancer. N Engl J Med 1989:822-8.
14. G.C. Zografos, M. Panou, N. Panou . Common risk factors of breast and ovarian cancer: recent view. International J Gynecol Cancer 2004;14:721–40.
15. Peterson ME, Schultz DJ, Reynolds C et al. Outcomes in breast cancer patients relative to marjin status after treatment with breast-conserving surgery and radiation therapy: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 1999;43:1029-35.
16. Joensuu H, Toikanen S, Klemi PJ.DNA index and S phase fraction and their combinations as prognostic factors in operable ductal breast carcinoma. Cancer 1990;66:331-40.
17. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24740 breast cancer cases. Cancer 1989;63:181-7.
18. Wilson FJ, Cox JD. Definitive, adjuvant, palliative radiation therapy in mammary cancer. In Donegan WL, Spratt JS, eds. Cancer of the breast. Philedelphia: WB Saunders; 1995. p. 505-18.